Paul Hastings LLP has extensive expertise in IPOs for common stock shares, acting on behalf of issuers and underwriters mainly focused on the oil and gas, chemicals energy transition, and infrastructure spheres. The team routinely represents investment banks, public companies, and venture capital funds, with New York-based Frank Lopez heading the firm’s global securities and capital markets practice. Also operating out of New York, Colin Diamond has vast knowledge in registered equity offerings, private placements, and convertible bond offerings, with Seo Salimi standing out for his. work in cross-border capital market transactions in the life sciences field.
L’éditorial du Legal 500
- Profil
Clients clés
- Goldman Sachs
- J.P. Morgan Securities
- Morgan Stanley
- Jefferies
- Barclays
- BofA Securities
- Piper Sandler and Co.
- TD Securities (USA) LLC
- Guggenheim Securities Inc.
- Leerink Partners, LLC
Points forts
- Represented Viking Therapeutics, Inc., as issuer, in its USD $632.5 million follow-on public offering of its common stock.
- Represented Kyverna Therapeutics, Inc., as issuer, in its upsized initial USD $366.9 million public offering.
- Advised Goldman Sachs & Co. LLC, J.P. Morgan, TD Cowen, and Stifel as joint bookrunning managers in connection with Syndax Pharmaceuticals’ USD $230 million public offering.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Frank Lopez; Colin Diamond; Eric Sibbitt; Jeff Hartlin; Seo Salimi; David Ambler